82 related articles for article (PubMed ID: 3544240)
1. [Use of pharmorubicin in cancer of the breast].
Ass NIa; Borisov VI
Sov Med; 1986; (10):36-9. PubMed ID: 3544240
[No Abstract] [Full Text] [Related]
2. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
Campora E; Nobile MT; Sertoli MR; Rosso R
Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
[No Abstract] [Full Text] [Related]
3. American symposium looks at new antineoplastic drug.
Korcok M
Can Med Assoc J; 1985 Jul; 133(1):66-7. PubMed ID: 3891062
[No Abstract] [Full Text] [Related]
4. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
Ventura GJ
J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
[No Abstract] [Full Text] [Related]
5. Epirubicin as adjuvant therapy in breast cancer.
Earl H; Iddawela M
Expert Rev Anticancer Ther; 2004 Apr; 4(2):189-95. PubMed ID: 15056049
[TBL] [Abstract][Full Text] [Related]
6. Epirubicin for adjuvant therapy in node-positive breast cancer.
Med Lett Drugs Ther; 2000 Feb; 42(1071):12-3. PubMed ID: 10725968
[No Abstract] [Full Text] [Related]
7. [New 2004 guidelines of the Breast Organ Committee of AGO].
Krankenpfl J; 2004; 42(3-4):81. PubMed ID: 15311888
[No Abstract] [Full Text] [Related]
8. Liposomal doxorubicin in breast cancer: new preparation. Much ado about nothing.
Prescrire Int; 2003 Jun; 12(65):93-5. PubMed ID: 12825572
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of breast cancer. Investigational treatment.
Jones SE
Ariz Med; 1974 Mar; 31(3):197-8. PubMed ID: 4362033
[No Abstract] [Full Text] [Related]
10. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.
Minisini AM; Andreetta C; Fasola G; Puglisi F
Expert Rev Anticancer Ther; 2008 Mar; 8(3):331-42. PubMed ID: 18366282
[TBL] [Abstract][Full Text] [Related]
11. Epirubicin: is it like doxorubicin in breast cancer? A clinical review.
Khasraw M; Bell R; Dang C
Breast; 2012 Apr; 21(2):142-9. PubMed ID: 22260846
[TBL] [Abstract][Full Text] [Related]
12. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
13. [Current status of epirubicin in the treatment of breast neoplasm].
Jiang ZF; Song SC
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):193-5. PubMed ID: 15949413
[No Abstract] [Full Text] [Related]
14. Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
Warner E; Hedley D; Andrulis I; Myers R; Trudeau M; Warr D; Pritchard KI; Blackstein M; Goss PE; Franssen E; Roche K; Knight S; Webster S; Fraser RA; Oldfield S; Hill W; Kates R
Clin Cancer Res; 1998 Jun; 4(6):1451-7. PubMed ID: 9626462
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin in combination chemotherapy for breast cancer: a preliminary report.
Ward HW
Br J Clin Pract; 1974 Apr; 28(4):137-8. PubMed ID: 4841023
[No Abstract] [Full Text] [Related]
16. Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer.
Arpino G; Ciocca DR; Weiss H; Allred DC; Daguerre P; Vargas-Roig L; Leuzzi M; Gago F; Elledge R; Mohsin SK
Breast Cancer Res Treat; 2005 Jul; 92(1):69-75. PubMed ID: 15980993
[TBL] [Abstract][Full Text] [Related]
17. [Comparative evaluation of the cardiotoxic effects of antineoplastic antibiotics adriamycin and pharmorubicin].
Valvere VIu; Shkhvatsabaia LV; Niu-Tian-de GB
Kardiologiia; 1989 Sep; 29(9):64-7. PubMed ID: 2687558
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.
Jones WG; Mattsson W
Cancer Treat Rep; 1984 Apr; 68(4):675-7. PubMed ID: 6585271
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.
Booser DJ; Esteva FJ; Rivera E; Valero V; Esparza-Guerra L; Priebe W; Hortobagyi GN
Cancer Chemother Pharmacol; 2002 Jul; 50(1):6-8. PubMed ID: 12111105
[TBL] [Abstract][Full Text] [Related]
20. Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.
Rivera E; Valero V; Esteva FJ; Syrewicz L; Cristofanilli M; Rahman Z; Booser DJ; Hortobagyi GN
Cancer Chemother Pharmacol; 2002 Apr; 49(4):299-302. PubMed ID: 11914909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
